Member Info for Time2Buy

If you are quick.

http://www.cbmagazine.co.uk/News_Article_JS.cfm?NewsID=8556&X=0&Y=0&YearViewed=2009&Newsmonth=06&EndDay=30&NoNews=0

Directors buying today. News released after the close.

Thanks for that. Backs up my thoughts.

Looking at the last results this is very cheap.

Looks like a pretty good company and charts showing an oversold position

Positivity from Panmure's today: http://www.citywire.co.uk/personal/-/news/markets-companies-and-funds/content.aspx?ID=349368&Page=1 "Panmure Gordon has....a buy and 20p target for Workspace"

Could see this back up trading around the 17p level

There was the ability to buy slightly below the offer prive but on a different stock CCGP. Mixed em up.

Full offer only.

LONDON (MarketWatch) -- Legal & General /quotes/comstock/23s!a:lgen (UK:LGEN 51.08, +1.23, +2.47%) was upped to overweight from equal-weight and has its price target lifted to 97 pence from 92 pence by Morgan Stanley, which said solvency fears around the U.K. insurer are overdone. "By the time Solvency 2 goes live in 2012, credit spreads should have narrowed further. With the shares trading almost at our bear case it looks like the market is pricing in our worst-case scenario, making the risk-reward skew particularly attractive, in our view," the broker said.

RNS Number : 3657V MDY Healthcare PLC 09 July 2009  MDY Healthcare plc participates in over-subscribed $8.1 million Series E financing for Medivance, Inc. 9 July 2009 - MDY Healthcare plc ('MDY Healthcare'), the strategic investor in healthcare companies, today announces that it has subscribed $1 million (approximately £630,000) in newly issued equity in Medivance, Inc ('Medivance'). This Series E financing of $8.1 million was led by affiliates of Black Rock, the US investment management company, and is intended to assist Medivance with funds for working capital, product development and to enable Medivance favorably to restructure its loans. The over-subscribed fund raising was heavily supported by existing shareholders. MDY Healthcare had invested approximately £2.5 million in Medivance as at 31 March 2009. This follow on investment in Series E preferred shares gives MDY Healthcare a holding of 9.4%, on a fully diluted basis. Medivance, the Colorado-based leader in the emerging field of therapeutic temperature management, has made excellent progress since MDY Healthcare first invested in December 2006, with the company's worldwide revenues increasing over three fold in this time. Additionally, Medivance's patented, FDA-approved Arctic Sun™ device has significantly expanded its market presence and is now used in approximately 90% of the top twenty US hospital heart programs and fourteen of the

In addition, the Company announces that in accordance with its investment strategy of investing globally in companies within the healthcare sector with a particular focus on medical technology, it is in the process of establishing a fund to invest in medtech companies in China. The directors have identified a large and growing demand in China for mid-range medical devices and equipment and therefore an opportunity for a medtech-focussed growth capital investment strategy to be deployed in China. A new specialist investment company for China medtech is being formed and will be administered and managed by MDY Healthcare. The Company, alongside other identified investors who specialise in international medical devices, will be the initial investors in the new entity.

Seems very low and just need one buyer to appear to really get this moving.

This is now looking far too cheap. What price will the traders be buying in at?

Share tips: buy RBS and DSG More share tips compiled by Hargreaves Lansdown. Also covered: Stagecoach, Kesa Electricals, Micro Focus International and McBride. Published: 1:49PM BST 29 Jun 2009 DSG International Buy at 24p (this week's price 23p), suggests Seymour Pierce. When adjusting for store restructurings across the electrical retailer's European stores, recent pre-tax profits materialised at the high end of expectations, notes Seymour. Furthermore, results of the store revamp programme have so far been encouraging while there remains significant potential to continuing reducing costs, highlights the broker. In addition, the recent raising of £300m has strengthened the capital base and should also aid the store revamp programme. Seymour concludes that while the shares are not necessarily cheap, restructured stores should improve earnings in 2011. http://www.telegraph.co.uk/finance/personalfinance/investing/shares-and-stock-tips/5685382/Share-tips-buy-RBS-and-DSG.html

Is actually looking very good now. Is there some news about driving this higher. Was always a BB fav

With a 0.5p divi and SP at this price the yield looks very attractive especially as many are stating that the property market has bottomed and buyers are coming back to the market. http://www.telegraph.co.uk/finance/newsbysector/supportservices/5750110/London-office-lets-increase-by-98pc.html

What a no brainer

"Since then, the Group has taken soundings from a number of trade parties and potential private equity buyers, which indicate that there is an appetite to purchase the whole Group. The review process has continued and the Board has to date received a number of indicative conditional proposals to make an offer for the entire issued share capital of the Company. This may or may not lead to such an offer being made. The Board will inform shareholders of further progress when appropriate."